Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials
2024 · Kidney Medicine · 19 citations
https://doi.org/10.1016/j.xkme.2024.100855
K
Kazuki Tanaka
Tokai University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
58
Papers
350
Citations
10
h-index
13
i10-index
Kazuki Tanaka is an academic researcher from Tokai University. The author has contributed to research in topics: Coronary Interventions and Diagnostics & Anesthesia and Pain Management & Peripheral Artery Disease Management. The author has an h-index of 10, co-authored 50 publications.
ORCID: 0009-0000-4683-5968Papers by this author
worksEffect of Renal Impairment on Clinical Outcomes After Mitral Valve Transcatheter Edge-to-Edge Repair
2025 · JACC Asia · 3 citations
https://doi.org/10.1016/j.jacasi.2024.10.025
MOESM1 of Unique binding modes for the broad neutralizing activity of single-chain variable fragments (scFv) targeting CD4-induced epitopes
2017 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.c.3887494_d1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat